CALGARY, AB, March 4, 2026 /CNW/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI) (FRA: 1N1) announces the Company's Board of Directors has granted 1,210,000 restricted share units ("RSUs") and 350,000 stock options ("Options") to certain directors, officers and employees of the Company, pursuant to the Company's stock option plan and restricted share unit plan (the "RSU Plan"), as applicable. Each Option is exercisable, once vested, to purchase one common share of the Company (a "Common Share") at $0.20 per share for a period of five years from the date of grant. Each vested RSU entitles the holder to receive one Common Share.
Read more at newswire.ca
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
